These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11860343)

  • 1. Recognition of multiple substrate motifs by the c-ABL protein tyrosine kinase.
    Wu JJ; Afar DE; Phan H; Witte ON; Lam KS
    Comb Chem High Throughput Screen; 2002 Feb; 5(1):83-91. PubMed ID: 11860343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the intrinsic kinase activity and substrate specificity of c-Abl and Bcr-Abl.
    Wu JJ; Phan H; Lam KS
    Bioorg Med Chem Lett; 1998 Sep; 8(17):2279-84. PubMed ID: 9873528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Src-Abl tyrosine kinase chimeras: replacement of the adenine binding pocket of c-Abl with v-Src to swap nucleotide and inhibitor specificities.
    Liu Y; Witucki LA; Shah K; Bishop AC; Shokat KM
    Biochemistry; 2000 Nov; 39(47):14400-8. PubMed ID: 11087392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of Bruton's tyrosine kinase by c-Abl.
    Bäckesjö CM; Vargas L; Superti-Furga G; Smith CI
    Biochem Biophys Res Commun; 2002 Dec; 299(3):510-5. PubMed ID: 12445832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide and protein library screening defines optimal substrate motifs for AKT/PKB.
    Obata T; Yaffe MB; Leparc GG; Piro ET; Maegawa H; Kashiwagi A; Kikkawa R; Cantley LC
    J Biol Chem; 2000 Nov; 275(46):36108-15. PubMed ID: 10945990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering the substrate specificity of the Abl tyrosine kinase.
    Till JH; Chan PM; Miller WT
    J Biol Chem; 1999 Feb; 274(8):4995-5003. PubMed ID: 9988744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target specificity analysis of the Abl kinase using peptide microarray data.
    Rychlewski L; Kschischo M; Dong L; Schutkowski M; Reimer U
    J Mol Biol; 2004 Feb; 336(2):307-11. PubMed ID: 14757045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the substrate specificity of the HER2/Neu tyrosine kinase using peptide libraries.
    Chan PM; Nestler HP; Miller WT
    Cancer Lett; 2000 Nov; 160(2):159-69. PubMed ID: 11053645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Identification of Protein Kinase Phosphorylation Site Motifs Using Combinatorial Peptide Libraries.
    Miller CJ; Turk BE
    Methods Mol Biol; 2016; 1360():203-16. PubMed ID: 26501912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The substrate specificity of the catalytic domain of Abl plays an important role in directing phosphorylation of the adaptor protein Crk.
    Amoui M; Miller WT
    Cell Signal; 2000 Oct; 12(9-10):637-43. PubMed ID: 11080615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nuclear tyrosine phosphorylation circuit: c-Jun as an activator and substrate of c-Abl and JNK.
    Barilá D; Mangano R; Gonfloni S; Kretzschmar J; Moro M; Bohmann D; Superti-Furga G
    EMBO J; 2000 Jan; 19(2):273-81. PubMed ID: 10637231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases.
    Mayer BJ; Hirai H; Sakai R
    Curr Biol; 1995 Mar; 5(3):296-305. PubMed ID: 7780740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.
    Ren R; Ye ZS; Baltimore D
    Genes Dev; 1994 Apr; 8(7):783-95. PubMed ID: 7926767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the c-Abl and Bcr-Abl tyrosine kinases.
    Hantschel O; Superti-Furga G
    Nat Rev Mol Cell Biol; 2004 Jan; 5(1):33-44. PubMed ID: 14708008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase.
    Oda T; Kujovich J; Reis M; Newman B; Druker BJ
    Oncogene; 1997 Sep; 15(11):1255-62. PubMed ID: 9315092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of B cell adaptor for PI3-kinase (BCAP) as an Abl interactor 1-regulated substrate of Abl kinases.
    Maruoka M; Suzuki J; Kawata S; Yoshida K; Hirao N; Sato S; Goff SP; Takeya T; Tani K; Shishido T
    FEBS Lett; 2005 Jun; 579(14):2986-90. PubMed ID: 15893754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the human c-Abl consensus DNA binding site.
    David-Cordonnier MH; Hamdane M; Bailly C; D'Halluin JC
    FEBS Lett; 1998 Mar; 424(3):177-82. PubMed ID: 9539146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways.
    Voss J; Posern G; Hannemann JR; Wiedemann LM; Turhan AG; Poirel H; Bernard OA; Adermann K; Kardinal C; Feller SM
    Oncogene; 2000 Mar; 19(13):1684-90. PubMed ID: 10763825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA.
    Kipreos ET; Wang JY
    Science; 1992 Apr; 256(5055):382-5. PubMed ID: 1566087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proline-rich sequences that bind to Src homology 3 domains with individual specificities.
    Alexandropoulos K; Cheng G; Baltimore D
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3110-4. PubMed ID: 7536925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.